tert-Butyl 3-(2,4-difluorophenyl)-3-hydroxyazetidine-1-carboxylate, 98%, 250mg

2-Chloro-4-methylpyrimidine, 98.0%, 5g

2-Bromothiazolo[5,4-b]pyridine, 95.0%, 250mg

N-(3-methylpyridin-4-yl)ethane-1,2-diamine, 95.0%, 50g

Tesevatinib, 99.21%, 5mg

Bis-PEG7-NHS ester, 500mg

6-Methoxypyridine-3-carbothioamide, 97.0%, 250mg

METHYL 6-BROMO-3-METHYL-1H-INDOLE-4-CARBOXYLATE, 95.0%, 100mg

2-Benzoylbenzoic acid, 95.0%, 100g

(5-Bromo-6-chloro-4-trifluoromethyl-pyridin-2-yl)-dimethyl-amine, 95.0%, 1g

3-Chloro-2-methyl-1-propene (stabilized with Stearyl 3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionate)>98.0%(GC)25mL

beta-Isocupreidine>98.0%(HPLC)(T)1g

(4-Chlorophenyl)(piperidin-3-yl)methanone hydrochloride, 95+%, 5g